Mersana Therapeutics Inc. (MRSN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.53
-0.02 (-3.62%)
At close: Jan 22, 2025, 3:59 PM
0.53
-0.42%
After-hours Jan 22, 2025, 07:11 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -171.67M | -204.21M | -170.06M | -88.05M | -28.21M | -64.26M | -38.71M | -13.70M | -16.43M |
Depreciation & Amortization | 1.52M | 927.00K | 855.00K | 1.01M | 1.25M | 1.26M | 928.00K | 655.00K | 297.00K |
Stock-Based Compensation | 21.14M | 21.52M | 18.41M | 7.17M | 4.87M | 3.88M | 1.42M | 668.00K | 349.00K |
Other Working Capital | -42.68M | 162.15M | 9.60M | 4.16M | -41.38M | -6.13M | -10.05M | 43.28M | 3.72M |
Other Non-Cash Items | -1.10M | -699.00K | 723.00K | 148.00K | 103.00K | 110.00K | -159.00K | 102.00K | 349.00K |
Deferred Income Tax | n/a | n/a | n/a | -86.00K | -222.00K | -386.00K | -134.00K | -102.00K | -349.00K |
Change in Working Capital | -18.76M | 133.10M | 10.09M | 5.11M | -45.53M | 4.18M | -6.03M | 43.97M | 6.15M |
Operating Cash Flow | -168.88M | -49.36M | -139.99M | -74.70M | -67.74M | -55.22M | -42.68M | 31.59M | -9.64M |
Capital Expenditures | -2.17M | -2.20M | -648.00K | -473.00K | -605.00K | -1.37M | -1.14M | -1.08M | -619.00K |
Acquisitions | n/a | 150.52M | n/a | n/a | 26.69M | n/a | n/a | n/a | n/a |
Purchase of Investments | -155.92M | -247.52M | n/a | n/a | -53.69M | n/a | -145.70M | n/a | -164.00K |
Sales Maturities Of Investments | 277.97M | 97.00M | n/a | 37.50M | 27.00M | 88.56M | 47.22M | n/a | n/a |
Other Investing Acitivies | n/a | -150.52M | n/a | 37.50M | -26.69M | 88.56M | -98.48M | n/a | -164.00K |
Investing Cash Flow | 119.88M | -152.72M | -648.00K | 37.03M | -27.29M | 87.19M | -99.62M | -1.08M | -783.00K |
Debt Repayment | -262.00K | -272.00K | 18.34M | -116.00K | 4.88M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 146.00K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.40M | 2.40M | 2.22M | 3.50M | 664.00K | 1.06M | 452.00K | 58.26M | 9.96M |
Financial Cash Flow | 94.67M | 153.02M | 63.65M | 230.41M | 97.70M | 1.06M | 68.60M | 58.26M | 9.96M |
Net Cash Flow | 45.68M | -49.06M | -76.99M | 192.74M | 2.67M | 33.04M | -73.71M | 88.76M | -459.00K |
Free Cash Flow | -171.05M | -51.56M | -140.64M | -75.17M | -68.35M | -56.59M | -43.82M | 30.50M | -10.26M |